The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both

American Journal of Ophthalmology

Volumn 170, Issue , 2016, Pages 240-

  Melles, Ronald B ^a   Marmor, Michael F ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FAT; HYDROXYCHLOROQUINE; TAMOXIFEN; ANTIRHEUMATIC AGENT;

BODY MASS; BODY WEIGHT; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG SCREENING; HIGH RISK PATIENT; HUMAN; IDEAL BODY WEIGHT; KIDNEY DISEASE; LETTER; LONG TERM CARE; LOW RISK PATIENT; MEDICAL INFORMATION; MUSCLE; NONHUMAN; OBESITY; OPHTHALMOLOGIST; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RETINOPATHY; RISK FACTOR; SCREENING TEST; SKIN; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TIME TO TREATMENT; TREATMENT DURATION; RETINA DISEASE;

ANTIRHEUMATIC AGENTS; HUMANS; HYDROXYCHLOROQUINE; OPHTHALMOLOGISTS; PREVALENCE; RETINAL DISEASES;

EID: 84993899475     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2016.06.045     Document Type: Letter

References (6)

1. 1 Browning, D.J., The prevalence of hydroxychloroquine retinopathy and toxic dosing, and the role of the ophthalmologist in reducing both. Am J Ophthalmol 166 (2016), ix–xi.
2. 2 McChesney, E.W., Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 75:1A (1983), 11–18.
3. 14 C in the rhesus monkey. Biochem Pharmacol 16 (1967), 2444–2447.
4. 4 Melles, R.B., Marmor, M.F., The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 132:12 (2014), 1453–1460.
5. 5 Francès, C., Cosnes, A., Duhaut, P., et al. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. Arch Dermatol 148 (2012), 479–484.
6. 6 Marmor, M.F., Kellner, U., Lai, T.Y., Melles, R.B., Mieler, W.F., Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). American Academy of Ophthalmology. Ophthalmology 123:6 (2016), 1386–1394.